Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes.
about
Pseudotype-based neutralization assays for influenza: a systematic analysis.A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon.Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell linesGeneration of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccinesCompletion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines.Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus.Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses.Biological and protective properties of immune sera directed to the influenza virus neuraminidase.Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells.Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease.The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent.The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells.Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles.Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism.Production of influenza pseudotyped lentiviral particles and their use in influenza research and diagnosis: an update.RNA replicons - a new approach for influenza virus immunoprophylaxis.Partial Protection against Porcine Influenza A Virus by a Hemagglutinin-Expressing Virus Replicon Particle Vaccine in the Absence of Neutralizing Antibodies.Virus replicon particles expressing porcine reproductive and respiratory syndrome virus proteins elicit immune priming but do not confer protection from viremia in pigs.Virion Background and Efficiency of Virion Incorporation Determine Susceptibility of Simian Immunodeficiency Virus Env-Driven Viral Entry to Inhibition by IFITM Proteins.Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection.Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapyAnalysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins.Rescue of influenza C virus from recombinant DNA.Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes.Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism.Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.A vesicular stomatitis pseudovirus expressing the surface glycoproteins of influenza A virus.The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells.Virus replicon particle vaccines expressing nucleoprotein of influenza A virus mediate enhanced inflammatory responses in pigs.1-Benzyl-3-cetyl-2-methylimidazolium Iodide (NH125) Is a Broad-Spectrum Inhibitor of Virus Entry with Lysosomotropic Features.Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigsA GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism
P2860
Q30374662-A91D9DE9-1C1E-433A-B533-B415686B45D4Q31037459-72188BD7-7F35-4730-9936-1968755106A4Q33405724-9CE4975C-C6AD-477E-87C3-BC32288FB891Q33657931-B09C3EE0-3F35-4F20-9A3B-FC3E057A97B6Q33892350-117309CA-7E32-41F4-B4BC-BAE49D2C7777Q34770423-DC9F8731-9BFE-4EAC-A10B-F3FDECADEF82Q34983662-1FFD56E1-6BC1-4387-B94E-FE021651B3B8Q34991399-951ADB96-FB13-482A-9710-42B34C13BE46Q35299800-1250A429-9C21-4727-811C-3F55D471E3E5Q35746584-22ABAB7C-D497-4990-880E-F64D65D14D75Q35930819-6BEF217A-9ED1-4A95-A1BF-D8F028F967ABQ35974128-E5074E3A-3647-4E36-B623-0C743F947FE8Q37281773-00146D4A-1DFA-4C03-B084-48651DC81B54Q37417924-186A5B4F-56B8-4490-A6A4-A704F055ED49Q37866816-5E76E04E-00CA-4261-A05C-D704122B3766Q37945198-3F4F2DC0-7B8F-4B47-B603-E13203DB5A8EQ38436945-2478CBAC-5786-469C-BA2C-FE11E1D22DDBQ38573583-2E0794BC-1CDA-455E-BEA6-A87A840B1166Q38733780-91B6EBD0-733C-4AB5-AE95-46869E1F47E5Q39142927-C126C7E5-61C7-4FBE-824E-AF833BB4F4CCQ39404803-92ED2001-B15E-43D2-89E0-31210E63A0F7Q40039979-80FA9B9C-05D4-4485-A65B-6BDB2EFD6526Q40096516-C7FA412B-5CC8-4FD3-AAF9-2E41FFBC09F1Q41506910-3E2EAD5E-75F9-4A3C-8E67-8E2E02F90A62Q41810186-673C1332-9C75-445E-B9B8-47A3194E87BAQ41928655-DBEF5013-2BD3-4F4C-9F1C-588ADD6259BEQ42212662-C060C59E-3531-4B8C-85CB-69552297CBE2Q45323651-541BA694-9E15-4DDF-AF17-62D5FB3222D9Q45324179-E1A8E7B4-1DF1-43B2-AF73-D66657D3E4CDQ54976877-C0EDDB58-886C-46A2-B12C-8BFB5B4D500CQ57197569-63648474-C131-4281-A019-0A20C726D6EDQ57252413-B0D39A27-957D-45D7-98FA-B57C2ABFB1AE
P2860
Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Use of influenza C virus glyco ...... stomatitis virus pseudotypes.
@en
Use of influenza C virus glyco ...... stomatitis virus pseudotypes.
@nl
type
label
Use of influenza C virus glyco ...... stomatitis virus pseudotypes.
@en
Use of influenza C virus glyco ...... stomatitis virus pseudotypes.
@nl
prefLabel
Use of influenza C virus glyco ...... stomatitis virus pseudotypes.
@en
Use of influenza C virus glyco ...... stomatitis virus pseudotypes.
@nl
P2093
P356
P1476
Use of influenza C virus glyco ...... stomatitis virus pseudotypes.
@en
P2093
Andrea Hanika
Birthe Larisch
Christel Schwegmann-Wessels
Georg Herrler
P304
P356
10.1099/VIR.0.80788-0
P407
P577
2005-05-01T00:00:00Z